Status:
COMPLETED
Detection of Acute Graft Rejection in Heart Transplant Patients by Estimation of T2
Lead Sponsor:
Central Hospital, Nancy, France
Conditions:
Acute Graft Rejection
Heart Transplantation
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The investigators propose a simple and non-invasive method to monitor heart transplant patients with MRI. Its diagnostic and prognostic values have already been assessed in two monocentric studies. Ot...
Eligibility Criteria
Inclusion
- Heart transplant patient
- Able to realize 4 couples Biopsy/MRI within 12 months after the transplant
- Mandatory enrolment in a social security plan
- Patient having signed an informed consent.
Exclusion
- Contraindication to MRI: pacemaker, ferromagnetic foreign body, etc
- Impossibility to undergo MRI: claustrophobia, morbid obesity, hospitalisation in intensive care unit, arrhythmia
- Pregnancy
- Patients under a measure of legal protection
Key Trial Info
Start Date :
February 18 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 27 2020
Estimated Enrollment :
116 Patients enrolled
Trial Details
Trial ID
NCT02261870
Start Date
February 18 2015
End Date
February 27 2020
Last Update
May 12 2020
Active Locations (10)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospices Civils de Lyon
Bron, France, 69677
2
CHU Grenoble
La Tronche, France, 38700
3
CHRU Nancy Brabois
Nancy, France
4
CHU de Nantes
Nantes, France, 44093